Corrigendum to “Implementation of HPV testing in Latin America” [J. Clin. Virol. 76, S1 (2016) S69–S73]

Corrigendum to “Implementation of HPV testing in Latin America” [J. Clin. Virol. 76, S1 (2016) S69–S73]

Journal of Clinical Virology 95 (2017) 12 Contents lists available at ScienceDirect Journal of Clinical Virology journal homepage: www.elsevier.com/...

104KB Sizes 0 Downloads 19 Views

Journal of Clinical Virology 95 (2017) 12

Contents lists available at ScienceDirect

Journal of Clinical Virology journal homepage: www.elsevier.com/locate/jcv

Corrigendum

Corrigendum to “Implementation of HPV testing in Latin America” [J. Clin. Virol. 76, S1 (2016) S69–S73]

MARK



Jose Jeronimoa, , Francesca Holmea, Rose Slavkovskya, Claudia Camelb a b

PATH, 2201 Westlake Ave., Seattle, WA 98121, USA Instancia por la Salud y el Desarrollo de las Mujeres, EdificioValsari, 7mo Nivel, Oficina 702, 6 Calle1-36, Zona 10, Guatemala City, Guatemala

The authors regret a disclosure was omitted from the Conflict of Interest statement. The additional disclosure is found below and the online version has been updated. “Jose Jeronimo was also the co-owner and deputy manager of Onco

DOI of original article: http://dx.doi.org/10.1016/j.jcv.2015.11.035 ⁎ Corresponding author. E-mail address: [email protected] (J. Jeronimo). http://dx.doi.org/10.1016/j.jcv.2017.06.005

1386-6532/ © 2017 Elsevier B.V. All rights reserved.

Prev International, a Peruvian company that offered cervical cancer screening services including Pap smear, HPV testing, colposcopy and surgical treatment.” The authors would like to apologise for any inconvenience caused.